Clarivate Enhances Cortellis CMC Intelligence Platform with Addition of Comprehensive Biologics Content

Clarivate Enhances Cortellis CMC Intelligence Platform with Addition of Comprehensive Biologics Content
USA - English
Share this article
accelerate innovation by bringing life-saving medicines to patients faster
LONDON, Jan. 20, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the enhancement of Cortellis CMC Intelligence™, the world's only organized, timely and accurate source of Chemistry, Manufacturing and Controls (CMC) regulations and local practices. The addition of new biologic CMC content and features will support pharma, biotech and generics organizations in their quest to efficiently and accurately plan and prepare their CMC regulatory dossier submissions.

Related Keywords

London ,City Of ,United Kingdom ,Catherine Daniel ,Mukhtar Ahmed ,International Pharmaceutical Rd Factbook ,Science Group ,Prnewswire Clarivate Plc ,Clarivate Plc ,Quality Assurance ,Quality Control ,Small Molecules ,Cortellis Regulatory Intelligence ,Pharmaceutical Rd Factbook ,Regulatory Reasons ,Initial Applications ,New Drugs ,லண்டன் ,நகரம் ஆஃப் ,ஒன்றுபட்டது கிஂக்டம் ,கேத்தரின் டேனியல் ,அறிவியல் குழு ,தரம் உறுதி ,தரம் கட்டுப்பாடு ,சிறிய மூலக்கூறுகள் ,ஒழுங்குமுறை ரீஸந்ஸ் ,ஆரம்ப பயன்பாடுகள் ,புதியது மருந்துகள் ,